Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/ IIIa blocker Integrelin in elective coronary intervention. IMPACT Investigators - Tcheng, JE; Harrington, RA; Kottke-Marchant, K (Circulation, 1995)